Miguel Ángel Seguí

parc tauli hospital universitari

31H指数

153论文数

3.9K被引数

收录论文 48

发表时间

Recommendations from the Spanish Society of Medical Oncology to advance the humanization in cancer care 西班牙医学肿瘤学会关于推进癌症护理人性化的建议

Clinical & Translational Oncology

IF2.5

2026-09-03

OAAI

Sergio Vázquez; Tamara Fenollosa Sanz; M. Helena Huertas; Julio Lambea; Ana López-González; Braulio Martín; Álvaro Romanos Nanclares; Cristina Sánchez; Miguel Ángel Seguí; Lucía Teijeira Sánchez; Jesús Corral; Isabela Díaz de Corcuera

Trop-2 overexpression as a prognostic marker in early triple-negative breast cancer: results from the GEICAM_CIBOMA trial Trop-2过表达作为早期三阴性乳腺癌的预后标志物：GEICAM_CIBOMA试验的结果

Breast Cancer Research

IF5.6

2026-08-28

OAAI

Federico Rojo; Sara Lopez-Tarruella; Begoña Bermejo; Laura Torrecillas; Manuel Ruiz-Borrego; Jose Bines; Jose G. M. Segalla; Jose A. Garcia-Saenz; Roberto Torres; Juan de la Haba-Rodriguez; Elena Garcia-Martinez; Henry Gomez; Antonio Llombart-Cussac; Maria Rodriguez de la Borbolla; Laura Perez Michel; Margarita Amenedo; Isaura Fernandez; Alvaro Rodriguez-Lescure; Jesus Cardenas; Jeferson Vinholes; Eduardo Martinez de Dueñas; Vega Iranzo Gonzalez-Cruz; Miguel Angel Segui; Sandra Perez-Buira; Jesus Herranz; Raul Rincon; Rosalia Caballero; Carlos H. Barrios; Miguel Martin; Angel Guerrero-Zotano

Adherence to the WCRF/AICR cancer prevention recommendations and mammographic density 遵守WCRF/AICR癌症预防建议与乳腺密度

Breast Cancer Research

IF5.6

2026-05-21

OAAI

Julia Fernández-Morata; Marina Pollán; Nerea Fernández de Larrea Baz; Vanessa Pachón-Olmos; Emma Ruíz-Moreno; Javier García-Pérez; Adela Castelló-Pastor; María Ángeles Sierra; Pilar Lucas; Rafael Llobet; Agostina Stradella; Blanca Cantos; Teresa Ramón y Cajal; Marta Santisteban; Miguel Ángel Seguí; Ana Santaballa Bertrán; Mónica Granja; Julia Camps-Herrero; Sabela Recalde; Miriam Méndez; Nuria Calvo Verges; Beatriz Pérez-Gómez; Roberto Pastor-Barriuso; Virginia Lope

Correction: Mammographic density and breast cancer pathological subtypes by menopausal status and body mass index 更正：乳腺X光密度和乳腺癌病理亚型按绝经状态和体重指数分类

Breast Cancer Research

IF5.6

2025-11-18

OAAI

Julia Fernández-Morata; Marina Pollán; Nerea Fernández de Larrea-Baz; Vanessa Pachón-Olmos; Javier García-Pérez; Adela Castelló; María Ángeles Sierra; Pilar Lucas; Rafael Llobet; Agostina Stradella; Blanca Cantos; Teresa Ramón y Cajal; Marta Santisteban; Miguel Ángel Seguí; Ana Santaballa Bertrán; Mónica Granja; Julia Camps-Herrero; Sabela Recalde; Beatriz Nuñez-García; Nuria Calvo Verges; Beatriz Pérez-Gómez; Roberto Pastor-Barriuso; Virginia Lope

Mammographic density and breast cancer pathological subtypes by menopausal status and body mass index 乳腺密度、乳腺癌病理亚型与绝经状态及体重指数的关系

Breast Cancer Research

IF5.6

2025-10-26

OAAI

Julia Fernández-Morata; Marina Pollán; Nerea Fernández de Larrea-Baza-Baz; Vanessa Pachón-Olmos; Javier García-Pérez; Adela Castelló; María Ángeles Sierra; Pilar Lucas; Rafael Llobet; Agostina Stradella; Blanca Cantos; Teresa Ramón y Cajal; Marta Santisteban; Miguel Ángel Seguí; Ana Santaballa Bertrán; Mónica Granja; Julia Camps-Herrero; Sabela Recalde; Beatriz Nuñez-García; Nuria Calvo Verges; Beatriz Pérez-Gómez; Roberto Pastor-Barriuso; Virginia Lope

Information needs and barriers to patient-centered care in oncology: EtnobreastHER2; an ethnographic study with HER2+ MBC patients and their healthcare providers 肿瘤学中患者为中心的护理信息需求与障碍：EtnobreastHER2；一项针对HER2+ MBC患者及其医疗保健提供者的民族志研究

Frontiers in Medicine

IF3

2025-10-23

OAAI

José Ángel García-Sáenz; Álvaro Rodríguez-Lescure; Silvia Antolin; Blanca Cantos; Miguel Ángel Seguí; María Antonia Gimón; Raül Rubio Renau; Carlota Solà Marsiñach; Jesús Martín Illán; Rocío Fonseca Vallejo; Yaiza Gimeno Guadalupe; Noelia Alfaro Oliver; Joaquín Gavilá

Do patients with HER2+ MBC and their HCPs speak the same language? Perceptions and uses of chronic disease and metastatic treatment arising from the EtnobreastHER2 study HER2+ MBC患者及其医疗保健专业人员（HCPs）是否使用相同的语言？源自EtnobreastHER2研究的对慢性疾病和转移性治疗的观点与用法

Patient Education and Counseling

IF3.1

2025-08-05

OAAI

Joaquín Gavilá; Álvaro Rodríguez-Lescure; Silvia Antolín; Blanca Cantos; Miguel Ángel Seguí; María Antonia Gimón; Raül Rubio Renau; Carlota Solà Marsiñach; Jesús Martín Illán; Rocío Fonseca Vallejo; Yaiza Gimeno Guadalupe; Noelia Alfaro Oliver; José Ángel García-Sáenz

Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?评估真实世界数据中乳腺癌患者口服内分泌治疗依从性的质量：真实世界数据有多真实？

CANCERS

IF4.4

2025-01-09

OAAI

Navarro-Sabate, A.; Font, R.; Espinas, J. A.; Sola, J.; Martinez-Soler, F.; Gil-Gil, M.; Vinas, G.; Tibau, A.; Borrell, M.; Segui, M.; Margeli, M.; Servitja, S.; Perez, C.; Domenech, M.; Nava, M.; Marin, M.; Gonzalez, S.; Borras, J. M.

16-year outcomes of radically treated localized gastric cancer (GC) patients (pt): Real-world data (RWD) of a Spanish institution

ANNALS OF ONCOLOGY

IF65.4

2024-06-01

PREAI

Macias Declara, I.; Soriano, S.; Ribera Fernandez, P.; Querol Ninerola, R.; Navarro, S.; Rivera Herrero, F.; Hierro Carbo, C.; Luna, A. L.; Perez Romero, N.; Sauri Nadal, T.; Segui Palmer, M. A.; Pericay Pijaume, C.

National expert consensus on home-administered oncologic therapies in Spain

FRONTIERS IN ONCOLOGY

IF3.3

2024-02-16

OAAI

Villegas, Eulalia; Arrunada, Maria; Casado, Miguel Angel; Gonzalez, Sonia; Moreno-Martinez, Maria Estela; Penuelas, Maria Angeles; Torres, Ana Maria; Sierra, Yanik; Segui, Miguel Angel

Magnetic resonance imaging (MRI) and clinicopathological analysis of triple-negative breast cancer (TNBC) patients (pts) treated with primary anthracyclines(A)/taxanes(TX)-based chemotherapy

CANCER RESEARCH

IF16.6

2023-03-01

PREAI

Boada, Marina Sierra; Fernandez, Luis Antonio; Dalmau, Elsa; Llort, Gemma; Marin, Maria; Andreu, Pablo; Lopez, Natalia; Climent, Carla; Rodriguez, Marta; Soriano, Sandra; Segui, Miquel Angel

Pembrolizumab plus eribulin in hormone receptore-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase II trial Pembrolizumab联合eribulin治疗激素受体阳性，HER2-negative，局部复发或转移性乳腺癌 (KELLY): 一项开放标签，多中心，单臂，II期试验

EUROPEAN JOURNAL OF CANCER

IF7.1

2021-05-01

PREAI

Perez-Garcia, Jose M.; Llombart-Cussac, Antonio; Cortes, Maria G.; Curigliano, Giuseppe; Lopez-Miranda, Elena; Alonso, Jose L.; Bermejo, Begona; Calvo, Lourdes; Caranana, Vicente; de la Cruz Sanchez, Susana; Vazquez, Raul M.; Prat, Aleix; Borrego, Manuel R.; Sampayo-Cordero, Miguel; Segui-Palmer, Miguel A.; Soberino, Jesus; Malfettone, Andrea; Schmid, Peter; Cortes, Javier

A phase II study of pembrolizumab and eribulin in patients with HR-positive/HER2-negative metastatic breast cancer previously treated with anthracyclines and taxanes (KELLY study)

CANCER RESEARCH

IF16.6

2020-02-15

PREAI

Manuel Perez-Garcia, Jose; Llombart-Cussac, Antonio; Holgado, Esther; Curigliano, Giuseppe; Lopez Miranda, Elena; Luis Alonso-Romero, Jose; Bermejo, Begona; Calvo, Lourdes; Caranana, Vicente; de la Cruz Sanchez, Susana; Gion Cortes, Maria; Marquez Vazquez, Raul; Prat, Aleix; Ruiz Borrego, Manuel; Sampayo, Miguel; Angel Segui, Miguel; Soberino, Jesus; Malfettone, Andrea; Schmid, Peter; Cortes, Javier

Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to Trastuzumab

TARGETED ONCOLOGY

IF4

2019-10-16

OAAI

Kolberg, Hans-Christian; Colleoni, Marco; Santi, Patricia; Demetriou, Georgia Savva; Angel Segui-Palmer, Miguel; Fujiwara, Yasuhiro; Hurvitz, Sara A.; Hanes, Vladimir

Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2019-05-10

OAAI

Bellet, Meritxell; Ahmad, Faten; Villanueva, Rafael; Valdivia, Carolina; Palomino-Doza, Julian; Ruiz, Ada; Gonzalez, Xavier; Adrover, Encarna; Azaro, Analia; Valls-Margarit, Maria; Lluis Parra, Josep; Aguilar, Juan; Vidal, Maria; Martin, Anastasi; Gavila, Joaquin; Escriva-de-Romani, Santiago; Perello, Antonia; Hernando, Cristina; Lahuerta, Ainhara; Zamora, Pilar; Reyes, Victoria; Alcalde, Maria; Masanas, Helena; Celiz, Pamela; Ruiz, Isabel; Gil, Miguel; Angel Segui, Miguel; de la Pena, Lorena

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials 通过更频繁的给药或序贯方案增加化疗的剂量强度: 对26项随机试验中37298名早期乳腺癌女性患者的患者水平荟萃分析

LANCET

IF88.5

2019-04-01

279

OAAI

Boddington, C.; Bradley, R.; Braybrooke, J.; Burrett, J.; Clarke, M.; Davies, C.; Davies, L.; Dodwell, D.; Duane, F.; Evans, V.; Gettins, L.; Godwin, J.; Gray, R.; Hills, R.; James, S.; Liu, H.; Liu, Z.; MacKinnon, E.; Mannu, G.; McGale, P.; McHugh, T.; Morris, P.; Pan, H.; Peto, R.; Read, S.; Taylor, C.; Wang, Y.; Wang, Z.; Bradley, R.; Braybrooke, J.; Gray, R.; Bergh, J.; Peto, R.; Gray, Richard; Bradley, Rosie; Braybrooke, Jeremy; Liu, Zulian; Peto, Richard; Davies, Lucy; Dodwell, David; McGale, Paul; Pan, Hongchao; Taylor, Carolyn; Barlow, William; Bliss, Judith; Bruzzi, Paolo; Cameron, David; Fountzilas, George; Loibl, Sibylle; Mackey, John; Martin, Miguel; Del Mastro, Lucia; Moebus, Volker; Nekljudova, Valentina; De Placido, Sabino; Swain, Sandra; Untch, Michael; Pritchard, Kathleen I.; Bergh, Jonas; Norton, Larry; Fasching, P.; Harbeck, N.; Untch, M.; Piedbois, P.; Gnant, M.; Steger, G.; Di Leo, A.; Dolci, S.; Francis, P.; Larsimont, D.; Nogaret, J. M.; Philippson, C.; Piccart-Gebhart, M. J.; Linn, S.; Peer, P.; Tjan-Heijnen, V.; Vliek, S.; Mackey, J.; Martin, M.; Slamon, D.; Bartlett, J. M. S.; Bramwell, V. H.; Chen, B. E.; Chia, S. K. L.; Gelmon, K.; Goss, P. E.; Levine, M. N.; Parulekar, W.; Pater, J. L.; Pritchard, K. I.; Rakovitch, E.; Shepherd, L. E.; Tu, D.; Whelan, T.; Berry, D.; Broadwater, G.; Cirrincione, C.; Muss, H.; Norton, L.; Weiss, R. B.; Shan, Y.; Shao, Y. F.; Wang, X.; Xu, B.; Zhao, D. B.; Bartelink, H.; Bijker, N.; Bogaerts, J.; Cardoso, F.; Cufer, T.; Julien, J. P.; Poortmans, P. M.; Rutgers, E.; van de Velde, C. J. H.; Carrasco, E.; Martin, M.; Segui, M. A.; Blohmer, J. U.; Costa, S. D.; Gerber, B.; Jackisch, C.; Loibl, S.; Nekljudova, V.; von Minckwitz, G.; Bruzzi, P.; Giuliano, M.; De laurentiis, M.; De Placido, S.; Del Mastro, L.; Bamia, C.; Fountzilas, G.; Koliou, G-A; Mavroudis, D.; A'Hern, R.; Bliss, J.; Cameron, D.; Ellis, P.; Kilburn, L.; Morden, J.; Yarnold, J. R.; Sadoon, M.; Tulusan, A. H.; Anderson, S.; Bass, G.; Costantino, J.; Dignam, J.; Fisher, B.; Geyer, C.; Mamounas, E. P.; Paik, S.; Redmond, C.; Swain, S.; Wickerham, L.; Wolmark, N.; Del Mastro, L.; Venturini, M.; Bighin, C.; Bruzzi, P.; Del Mastro, L.; Pastorino, S.; Pronzato, P.; Sertoli, M. R.; Barlow, W.; Bergh, J.; Foukakis, T.; Pritchard, K. I.; Swain, S.; Cameron, D.; Albain, K.; Anderson, S.; Arriagada, R.; Barlow, W.; Bartlett, J.; Bergsten-Nordstrom, E.; Bliss, J.; Boccardo, F.; Bradley, R.; Brain, E.; Braybrooke, J.; Carey, L.; Clarke, M.; Coates, A.; Coleman, R.; Correa, C.; Costantino, J.; Cuzick, J.; Davidson, N.; Davies, C.; Davies, L.; Di Leo, A.; Dodwell, D.; Dowsett, M.; Duane, F.; Ewertz, M.; Forbes, J.; Francis, P.; Gelber, R.; Gnant, M.; Goldhirsch, A.; Goodwin, P.; Gray, R.; Hayes, D.; Hill, C.; Ingle, J.; Jagsi, R.; Janni, W.; Liu, Z.; Loibl, S.; MacKinnon, E.; Mannu, G.; Martin, M.; McGale, P.; Mukai, H.; Nekljudova, V.; Norton, L.; Ohashi, Y.; Paik, S.; Pan, H.; Peto, R.; Piccart, M.; Pierce, L.; Poortmans, P.; Raina, V.; Ravdin, P.; Rea, D.; Regan, M.; Robertson, J.; Rutgers, E.; Slamon, D.; Sparano, J.; Steger, G.; Taylor, C.; Tutt, A.; Viale, G.; Wang, X.; Whelan, T.; Wilcken, N.; Wolmark, N.; Wood, W.; Zambetti, M.

A phase II study of pembrolizumab and eribulin in patients with HR-positive/HER2-negative metastatic breast cancer previously treated with anthracyclines and taxanes (KELLY study)

CANCER RESEARCH

IF16.6

2018-07-01

PREAI

Perez Garcia, Jose Manuel; Llombart, Antonio; Alonso, Jose Luis; Bermejo, Begona; Calvo, Lourdes; Caranana, Vicente; Curigliano, Giuseppe; de la Cruz Sanchez, Susana; Gion Cortes, Maria; Marquez Vazquez, Raul; Prat, Aleix; Ruiz Borrego, Manuel; Sampayo, Miguel; Schmid, Peter; Angel Segui, Miguel; Cortes, Javier; Holgado, Esther

Multicenter open-label, phase II trial, to evaluate the efficacy and safety of liposomal irinotecan (nal-IRI) for progressing brain metastases in patients with HER2-negative breast cancer (The Phenomenal Study)

CANCER RESEARCH

IF16.6

2018-07-01

PREAI

Cortes, Javier; Paez, David; Perez Garcia, Jose Manue; Blanch Tormo, Salvador; Amillano Parraga, Kepa; Ruiz Borrego, Manuel; Anton Torres, Antonio; Fernandez, Maria; Alba Conejo, Emilio; Segui Palmer, Miguel Angel; Ribugent, Joan Dorca; Lopez Lopez, Rafael; Margeli Vila, Mireia; Aguirre, Elena; Llombart, Antonio

Predictive and Prognostic Brain Metastases assessment in luminal Breast cancer Patients: Fn14 and grP94 from Diagnosis to Prophylaxis

FRONTIERS IN ONCOLOGY

IF3.3

2017-12-01

OAAI

Martinez-Aranda, Antonio; Hernandez, Vanessa; Moreno, Ferran; Baixeras, Nuria; Cuadras, Daniel; Urruticoechea, Ander; Gil-Gil, Miguel; Vidal, Noemi; Andreu, Xavier; Segui, Miquel A.; Ballester, Rosa; Castella, Eva; Sierra, Angels

Fulvestrant plus LHRH analogues in male with synchronous breast and prostate cancer

ANNALS OF ONCOLOGY

IF65.4

2017-08-01

OAAI

Vila, C. Martinez; Fernandez-Morales, L. A.; Oliveres, H.; Marin, M.; Ribera, P.; Pardo, J. C.; Dalmau, E.; Segui, M. A.

研究方向